EUPRAXIA PHARMACEUTICALS INC. Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price
EUPRAXIA PHARMACEUTICALS INC. (EPRX) reported Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price of 4.71 CAD/shares for the 12-month period ending 2024-12-31, per its 40-F filed 2026-03-13.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice · last filed 2026-03-13
| Period end | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price 12 month |
|---|---|
| 2024-12-31 | 4.71 CAD/shares 40-F · filed 2026-03-13 |
| 2023-12-31 | 2.00 CAD/shares 40-F · filed 2025-03-20 |